Ebit Değişiklik Tarih
AstraZeneca USD 3.16B 3.95B 2026-06
Cassava Sciences USD -11.17M 2.38M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Roche Holding CHF 11.46B 1.91B 2026-06
West Pharmaceutical Services USD 179.1M 2M 2026-06